Skip to main content
Rural Health Information Hub

Website Search Results for: mmwr

354 webpages matched your search. Here are matches 291 - 300:

291. Notes from the Field: Prevalence of Previous Dengue Virus Infection Among Children and Adolescents Aged 7–16 Years — American Samoa, September–October 2023 - Resources
Date: Aug 2024

Results of a serosurvey of 887 students in American Samoa who were tested for dengue immunoglobulin G. Information on prevalence of previous dengue virus infection among school-age children and adolescents was needed to guide decisions on dengue vaccine implementation.

...MMWR (Morbidity and Mortality Weekly Report), 73(31), 686-688 08/2024 Centers for Disease Control...

292. Human Papillomavirus Vaccination Coverage Among Adolescent Girls Aged 13–17 Years — U.S.-Affiliated Pacific Islands, 2013–2023 - Resources
Date: Aug 2024

Reports trends in human papillomavirus (HPV) vaccination coverage among adolescent girls since the vaccines were introduced in U.S.-affiliated Pacific Island jurisdictions.

...MMWR (Morbidity and Mortality Weekly Report), 73(33), 715-721 08/2024 Centers for Disease Control...

293. Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged <8 Months — United States, April 2024 - Resources
Date: Sep 2024

Reports on maternal respiratory syncytial virus (RSV) vaccination and administration of RSV antibody (nirsevimab) to infants. Includes data by location of residence for rural and nonrural areas.

...MMWR (Morbidity and Mortality Weekly Report), 73(38), 837-843 09/2024 Centers for Disease Control...

294. Vaccination Coverage by Age 24 Months Among Children Born During 2017–2021 — U.S.-Affiliated Pacific Islands - Resources
Date: Sep 2024

Reports estimated vaccination coverage with selected vaccines and vaccine series by age 24 months among children born during 2017–2021 in the U.S.-affiliated Pacific Islands. Includes data for each jurisdiction and year.

...MMWR (Morbidity and Mortality Weekly Report), 73(38), 854-859 09/2024 Centers for Disease Control...

295. Nirsevimab Effectiveness Against Medically Attended Respiratory Syncytial Virus Illness and Hospitalization Among Alaska Native Children — Yukon-Kuskokwim Delta Region, Alaska, October 2023–June 2024 - Resources
Date: Nov 2024

Reports on effectiveness of nirsevimab in preventing respiratory syncytial virus (RSV) associated hospitalization for Alaska Native infants in their first RSV season and against medically attended illness for children in their first and second seasons in Alaska's Yukon-Kuskokwim Delta. Includes data by community type for the hub town with regional hospital and outlying villages.

...MMWR (Morbidity and Mortality Weekly Report), 73(45), 1015-1021 11/2024 Centers for Disease Control...

296. Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — National Healthcare Safety Network, United States, 2023–24 Respiratory Virus Season - Resources
Date: Oct 2024

Reports on influenza and COVID-19 vaccination coverage among healthcare personnel working in acute care hospitals and nursing homes during the 2023-2024 respiratory virus season. Includes data by workplace location for rural and urban areas.

...MMWR (Morbidity and Mortality Weekly Report), 73(43), 966-972 10/2024 Centers for Disease Control...

297. Influenza, COVID-19, and Respiratory Syncytial Virus Vaccination Coverage Among Adults — United States, Fall 2024 - Resources
Date: Nov 2024

Provides estimates of vaccination coverage and intent to vaccinate for influenza, COVID-19, and respiratory syncytial virus (RSV) among adults. Includes data for rural, suburban, and urban areas.

...MMWR (Morbidity and Mortality Weekly Report), 73(46), 1044-1051 11/2024 Centers for Disease Control...

298. Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment, and Telehealth Use in Adults — National Center for Health Statistics Rapid Surveys System, United States, October–November 2023 - Resources
Date: Oct 2024

Reports national estimates of the prevalence and treatment of attention-deficit/hyperactivity disorder (ADHD) among U.S. adults. Includes data on adults with an ADHD diagnosis in metropolitan and nonmetro areas.

...MMWR (Morbidity and Mortality Weekly Report), 73(40), 890-895 10/2024 Centers for Disease Control...

299. Notes from the Field: Seroprevalence of Highly Pathogenic Avian Influenza A(H5) Virus Infections Among Bovine Veterinary Practitioners — United States, September 2024 - Resources
Date: Feb 2025

Presents findings from testing 150 bovine veterinary practitioners for highly pathogenic avian influenza (HPAI) A(H5) virus infection. Discusses the utility of seroprevalence assessments of recent HPAI A(H5) infection among practitioners at increased risk for exposure.

...MMWR (Morbidity and Mortality Weekly Report), 74(4), 50-52 02/2025 Centers for Disease Control...

300. Controlled Substance Prescribing Patterns Among Fatal Overdose Decedents with an Opioid, Stimulant, or Both Contributing to Death — Pennsylvania, 2017–2022 - Resources
Date: Apr 2025

Reports on deaths involving opioids without stimulants, deaths involving stimulants without opioids, and deaths involving both opioids and stimulants in Pennsylvania between 2017 and 2022. Includes data for rural and urban areas. Discusses the role of opioid prescribing on overdose deaths.

...MMWR (Morbidity and Mortality Weekly Report), 74(12), 205-209 04/2025 Centers for Disease Control...